PHP1B is characterized by end-organ resistance to several endocrine hormones, including parathyroid hormone (PTH) leading to hypocalcaemia and hyperphosphatemia, and thyroid stimulating hormone (TSH) leading to clinical or subclinical hypoparathyroidism. This evidence concerns the gene PTH and hypoparathyroidism.